170 related articles for article (PubMed ID: 30762589)
1. Metabolic Monitoring of Child and Adolescent Patients on Atypical Antipsychotics by Psychiatrists and Primary Care Providers.
Wakefield S; Aligeti M; Rachamallu V; Baronia R; Aynampudi R; Parmar A; Peterson P; Masodkar K
Am J Ther; 2020; 27(5):e425-e430. PubMed ID: 30762589
[TBL] [Abstract][Full Text] [Related]
2. Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
Coughlin M; Goldie CL; Tranmer J; Khalid-Khan S; Tregunno D
Can J Psychiatry; 2018 Apr; 63(4):240-249. PubMed ID: 29528720
[TBL] [Abstract][Full Text] [Related]
3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
5. The effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.
Cohen S; Bostwick JR; Marshall VD; Kruse K; Dalack GW; Patel P
J Clin Pharm Ther; 2020 Dec; 45(6):1398-1404. PubMed ID: 32767599
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
DelMonte MT; Bostwick JR; Bess JD; Dalack GW
J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
[TBL] [Abstract][Full Text] [Related]
7. Improving Adherence to Atypical Antipsychotic Agent Screening Guidelines in Pediatric Patients: A Quality Improvement Project Within an Integrated Community Mental Health Setting.
Featherston EL; Dihigo S; Gilder RE
J Am Psychiatr Nurses Assoc; 2018; 24(4):352-359. PubMed ID: 29357722
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Metabolic Effects in French-Canadian Children and Adolescents Treated with Second-Generation Antipsychotics in Monotherapy or Polytherapy: A 24-Month Descriptive Retrospective Study.
Ilies D; Huet AS; Lacourse E; Roy G; Stip E; Amor LB
Can J Psychiatry; 2017 Dec; 62(12):827-836. PubMed ID: 28673098
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of antipsychotics in prepubertal children: a retrospective chart review.
Ebert T; Midbari Y; Shmilovitz R; Kosov I; Kotler M; Weizman A; Ram A
J Child Adolesc Psychopharmacol; 2014 May; 24(4):218-22. PubMed ID: 24816004
[TBL] [Abstract][Full Text] [Related]
10. Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naïve French Canadian patients.
Roy G; Bedard A; Desmarais PA; Jourdain F; Allen S; Michaud D; Ben Amor L
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):479-87. PubMed ID: 21186966
[TBL] [Abstract][Full Text] [Related]
11. Child and adolescent psychiatrists' reported monitoring behaviors for second-generation antipsychotics.
Rodday AM; Parsons SK; Mankiw C; Correll CU; Robb AS; Zima BT; Saunders TS; Leslie LK
J Child Adolesc Psychopharmacol; 2015 May; 25(4):351-61. PubMed ID: 25918843
[TBL] [Abstract][Full Text] [Related]
12. Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs.
Morrato EH; Druss B; Hartung DM; Valuck RJ; Allen R; Campagna E; Newcomer JW
Arch Gen Psychiatry; 2010 Jan; 67(1):17-24. PubMed ID: 20048219
[TBL] [Abstract][Full Text] [Related]
13. Differences in body mass index z-scores and weight status in a Dutch pediatric psychiatric population with and without use of second-generation antipsychotics.
de Hoogd S; Overbeek WA; Heerdink ER; Correll CU; de Graeff ER; Staal WG
J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):166-73. PubMed ID: 22506734
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications.
Panagiotopoulos C; Ronsley R; Davidson J
Can J Psychiatry; 2009 Nov; 54(11):743-9. PubMed ID: 19961662
[TBL] [Abstract][Full Text] [Related]
15. Metabolic monitoring of pediatric patients prescribed second-generation antipsychotic medication.
Roebuck JH
J Child Adolesc Psychiatr Nurs; 2024 Feb; 37(1):e12438. PubMed ID: 37586850
[TBL] [Abstract][Full Text] [Related]
16. Second-Generation Antipsychotic Utilization and Metabolic Parameter Monitoring in an Inpatient Pediatric Population: A Retrospective Analysis.
Nolt VD; Kibler AV; Wilkening GL; Fabian TJ
Paediatr Drugs; 2017 Apr; 19(2):139-146. PubMed ID: 28074349
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.
Uzal NE; Chavez B; Kosirog ER; Billups SJ; Saseen JJ
Ann Pharmacother; 2018 Feb; 52(2):160-165. PubMed ID: 28884591
[TBL] [Abstract][Full Text] [Related]
18. Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.
Dinnissen M; Dietrich A; van der Molen JH; Verhallen AM; Buiteveld Y; Jongejan S; Troost PW; Buitelaar JK; van den Hoofdakker BJ; Hoekstra PJ
J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):13-18. PubMed ID: 33347017
[TBL] [Abstract][Full Text] [Related]
19. Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based intervention.
Lee J; Dalack GW; Casher MI; Eappen SA; Bostwick JR
J Clin Pharm Ther; 2016 Apr; 41(2):209-13. PubMed ID: 26919449
[TBL] [Abstract][Full Text] [Related]
20. Development of Metabolic Syndrome in Drug-Naive Adolescents After 12 Months of Second-Generation Antipsychotic Treatment.
Sjo CP; Stenstrøm AD; Bojesen AB; Frølich JS; Bilenberg N
J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):884-891. PubMed ID: 28783382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
